alitretinoin
Drug Details
- Generic Name
- alitretinoin
- Brand Names
- PANRETIN
- Application Number
- NDA020886
- Sponsor
- Advanz Pharma (US) Corp.
- NDC Codes
- 1
- Dosage Forms
- GEL
- Routes
- TOPICAL
- Active Ingredients
- ALITRETINOIN
Indications and Usage
1 INDICATIONS AND USAGE 1.1 Kaposi’s Sarcoma PANRETIN GEL is indicated for topical treatment of cutaneous lesions in adults with AIDS related Kaposi’s sarcoma (KS). Limitations of Use: PANRETIN GEL is not indicated when systemic anti-KS therapy is required (including more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement) [see Clinical Studies ( 14.1 )] . PANRETIN GEL is a retinoid indicated for the topical treatment of cutaneous lesions in adults with AIDS-related Kaposi’s sarcoma (KS). Limitations of Use : PANRETIN GEL is not indicated when systemic anti-Kaposi’s sarcoma therapy is required.